Predictors of Unfavorable Outcomes among Patients with Newly Diagnosed Pulmonary Tuberculosis
Research in Clinical Pharmacy · 2024
DOI: 10.59931/rcp.24.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2024. Verfasst von Humayera Kabir Hana und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Humayera Kabir Hana, Sania Siddiqui, Siti Maisharah Sheikh Ghadzi, Irfhan Ali Hyder Ali, Siew Chin Ong, Nur Hafzan Md Hanafiah, Sabariah Noor Harun. R Clin Pharm 2024;2:18-26. https://doi.org/10.59931/rcp.24.0003
Zitieren
APA
Hana, H. K., Siddiqui, S., Ghadzi, S. M. S., Ali, I. A. H., Ong, S. C., Hanafiah, N. H. M., & Harun, S. N. (2024). Predictors of Unfavorable Outcomes among Patients with Newly Diagnosed Pulmonary Tuberculosis. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.24.0003
Vancouver
Hana HK, Siddiqui S, Ghadzi SMS, Ali IAH, Ong SC, Hanafiah NHM, et al. Predictors of Unfavorable Outcomes among Patients with Newly Diagnosed Pulmonary Tuberculosis. Research in Clinical Pharmacy. 2024. doi:10.59931/rcp.24.0003
BibTeX
@article{Hana2024,
author = {Hana, Humayera Kabir and Siddiqui, Sania and Ghadzi, Siti Maisharah Sheikh and Ali, Irfhan Ali Hyder and Ong, Siew Chin and Hanafiah, Nur Hafzan Md and Harun, Sabariah Noor},
title = {Predictors of Unfavorable Outcomes among Patients with Newly Diagnosed Pulmonary Tuberculosis},
journal = {Research in Clinical Pharmacy},
year = {2024},
doi = {10.59931/rcp.24.0003}
}
EUVIMED